{"context":{"query":">>pharmgkb_gene>>pharmgkb","source_dataset":"pharmgkb_gene","target_dataset":"pharmgkb"},"stats":{"queried":1,"total":24,"mapped":1},"pagination":{"has_next":false},"schema":"id|name|type|clinical_annotation_count|variant_annotation_count|pathway_count","mappings":[{"input":"PA37302","source":"PA37302|vascular endothelial growth factor A","targets":["PA10004|adalimumab|Drug|18|118|0","PA10040|cetuximab|Drug|15|87|1","PA10810|pemetrexed|Drug|12|29|1","PA130232992|bevacizumab|Drug|24|162|1","PA130620651|anthracyclines and related substances|Drug Class|192|731|0","PA150481189|taxanes|Drug Class|138|529|0","PA162363968|lenalidomide|Drug|4|23|0","PA162372840|sunitinib|Drug|16|138|2","PA162373091|panitumumab|Drug|6|39|1","PA164746012|ranibizumab|Drug|7|79|0","PA164771236|pegaptanib|Drug|1|2|0","PA165291492|pazopanib|Drug|2|27|1","PA166118342|aflibercept|Drug|0|1|1","PA166165203|carfilzomib|Drug|0|4|0","PA166306001|VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors|Drug Class|24|164|0","PA448068|salbutamol|Drug|21|59|2","PA448871|celecoxib|Drug|6|44|2","PA449247|dexamethasone|Drug|14|55|2","PA449456|enalapril|Drug|10|44|0","PA449476|epirubicin|Drug|49|175|0","PA451346|sildenafil|Drug|5|8|0","PA451644|thalidomide|Drug|26|31|0","PA451906|warfarin|Drug|90|1220|2","PA7000|sorafenib|Drug|40|80|3"]}]}